for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cronos Group Inc

CRON.TO

Latest Trade

7.64CAD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

5.82

 - 

12.24

As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
7.64
Open
--
Volume
--
3M AVG Volume
14.08
Today's High
--
Today's Low
--
52 Week High
12.24
52 Week Low
5.82
Shares Out (MIL)
349.89
Market Cap (MIL)
2,670.69
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q3 2020 Cronos Group Inc Earnings Call

Latest Developments

More

Cronos Group Inc - Appointed Kurt Schmidt President And CEO

Cronos Group Reports Q2 Net Loss Per Share $0.31

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cronos Group Inc

Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivations Ltd, Cronos Israel G.S. Manufacturing Ltd, Cronos Israel G.S. Store Ltd and Cronos Israel G.S. Pharmacies Ltd.

Industry

Biotechnology & Drugs

Contact Info

Suite 300, 111 Peter Street

TORONTO, ON

M5V 2G9

Canada

+1.416.5040004

https://thecronosgroup.com/

Key Stats

3.08 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.0K

2018

0.0K

2019

0.0K

2020(E)

0.0K
EPS (USD)

2017

-0.008

2018

-0.081

2019

3.330

2020(E)

-0.168
Price To Earnings (TTM)
11.67
Price To Sales (TTM)
64.81
Price To Book (MRQ)
1.22
Price To Cash Flow (TTM)
3.18
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
48.79
Return on Equity (TTM)
32.26

Latest News

Latest News

BRIEF-Cronos Group Reports 2020 First Quarter Results

* CRONOS GROUP INC - QTRLY CONSOLIDATED NET REVENUE $8.43 MILLION VERSUS $3 MILLION

Altria CEO Howard Willard steps down, finance head to succeed

Altria Group Inc <MO.N> said on Friday Chief Executive Officer Howard Willard has stepped down, ending a near two-year tumultuous term at the helm marked by heightened scrutiny of the tobacco giant's bet on e-cigarette maker Juul.

BRIEF-Cronos Group Says In Accordance With Investor Rights Agreement And Altria's Submission, Board Elected Heather Newman As A Director

* CRONOS GROUP - IN ACCORDANCE WITH INVESTOR RIGHTS AGREEMENT AND ALTRIA'S SUBMISSION, BOARD ELECTED HEATHER NEWMAN AS A DIRECTOR Source text: (https://bit.ly/39ZeNnv) Further company coverage:

BRIEF-Cronos Group To Restate Certain 2019 Unaudited Interim Financial Statements

* CRONOS GROUP TO RESTATE CERTAIN 2019 UNAUDITED INTERIM FINANCIAL STATEMENTS

BRIEF-Cronos Group To Delay 2019 Q4 And Full-Year Earnings Release And Conference Call

* CRONOS GROUP TO DELAY 2019 Q4 AND FULL-YEAR EARNINGS RELEASE AND CONFERENCE CALL

Pot producers Cronos and Tilray report lower prices, soaring expenses

Cronos Group Inc <CRON.TO> <CRON.N> and Tilray Inc <TLRY.O> both reported selling prices that nearly halved, while expenses for both the Canadian pot producers soared in the third quarter.

Pot company Cronos Group posts bigger quarterly loss

Cronos Group Inc reported a bigger quarterly loss on Tuesday, as the Canadian marijuana producer was weighed down by lower margins and surge in expenses.

Pot company Cronos warns of wider second-half loss on higher costs; shares tumble

Canada's Cronos Group <CRON.TO> shares reversed course to trade down after the pot company forecast a wider second-half loss compared to the first, even as sales soar, as it spends on developing new products and expanding abroad.

Pot company Cronos posts wider loss as expenses soar

Canadian marijuana company Cronos Group reported a wider quarterly core loss on Thursday, as it struggled with rising costs.

Altria to marry pot with big tobacco in $1.8 billion Cronos deal

Marlboro cigarette maker Altria Group Inc announced a $1.8 billion investment in Cronos Group Inc on Friday, which could give it up to 55-percent ownership of the Canadian cannabis producer.

Altria to invest $1.8 bln in Canadian cannabis producer Cronos

Canada's Cronos Group Inc said on Friday Marlboro cigarette maker Altria Group Inc will invest $1.8 billion in the cannabis producer, giving it a 45 percent stake in the company.

Altria in deal talks with cannabis company Cronos Group

Marlboro cigarette maker Altria Group Inc <MO.N> is in discussions with Canadian cannabis producer Cronos Group Inc <CRON.TO> about making a possible investment, Cronos said on Monday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up